MM

Maheshan Mehta

Active Director Director DIN 09050944
DIN 09050944 First appointment Jan 2021 Primary industry Trading
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Jan 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Maheshan Mehta

Data last updated:

Maheshan Mehta is a Director at Lisica Chemicals Private Limited (since 2026) and Director at Capson Pharmaceuticals Private Limited (since 2021). The companies operate in Trading.

DIN 09050944
Primary Designation Director
Industry Trading
First Appointment 15 Jan 2021
Oldest Company Age 15 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Lisica Chemicals Private Limited U46691BR2026PTC085979
Director28 Jun 20262026Active
Director15 Jan 20212011Active

Board colleagues of Maheshan Mehta

Directorship timeline

Open interactive timeline →
Capson Pharmaceuticals Private Limited
Lisica Chemicals Private Limited
Premium access

Shareholding and investment profile for Maheshan Mehta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Maheshan Mehta

Maheshan Mehta currently holds 2 directorships: Lisica Chemicals Private Limited (Director, since 28 Jun 2026); Capson Pharmaceuticals Private Limited (Director, since 15 Jan 2021).

Maheshan Mehta was first appointed on 15 Jan 2021 as Director at Capson Pharmaceuticals Private Limited. The most recent appointment on record is 28 Jun 2026 at Lisica Chemicals Private Limited.

The current boards of Maheshan Mehta's companies include Sushila Prasad (Lisica Chemicals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available